← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2003Last known activity
Jul 18, 2025
Acquired by Patheon → Thermo Fisher Scientific on Nov 19, 2013
Timeline
1900s
- Jun 1, 1902
DSM— Founded
2000s
- Jun 11, 2008
Valley Research Group— Acquired
2010s
- Feb 25, 2011
Martek Biosciences— Acquired
- May 18, 2012
Ocean Nutrition— Acquired
- Jun 25, 2012
Kensey Nash Corporation— Acquired
- Dec 18, 2012
Fortitech— Acquired
- Apr 8, 2013
Tortuga Companhia Zootécnica Agrária— Acquired
- Jun 28, 2013
Unitech Industries Ltd— Acquired
- Nov 19, 2013
Patheon— Acquired By
- Mar 31, 2015
Aland (Jiangsu) Nutraceutical— Acquired
- Aug 29, 2017
- Sep 22, 2017
Twilmij— Acquired
- Dec 22, 2017
Biocare Copenhagen A/S— Acquired
- Dec 29, 2017
Amyris Brasil Pesquisa e Desenvolvimento— Acquired
- May 13, 2019
SRF Limited— Acquired
Drugs by trial phase (69 distinct, 104 trials)
Phase 3 (10 own, 1 via acquisition)
Phase 2 (12 own, 4 via acquisition)
Phase 1 (2 own, 5 via acquisition)
Other trials (34 own, 1 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Arrhythmias, Cardiac
- Attention Deficit Disorder with Hyperactivity
- Birth Weight
- Bone Diseases, Metabolic
- Cachexia
- Carcinoma, Non-Small-Cell Lung
- Celiac Disease
- Chronic Disease
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Diabetes, Gestational
- Diabetes Mellitus, Type 2
- Eclampsia
- Fatty Liver
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Growth Disorders
- Hypertension, Pregnancy-Induced
- Infant Death
- Insulin Resistance
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Malnutrition
- Metabolic Syndrome
- Non-alcoholic Fatty Liver Disease
- Osteoporosis
- Overweight
- Perinatal Death
- Pre-Eclampsia
- Premature Birth
- Pulmonary Disease, Chronic Obstructive
- Rectal Neoplasms
- Retinitis
- Retinitis Pigmentosa
- Wasting Syndrome
Subsidiaries (12 direct, 16 total across the full acquisition tree)
- Aland (Jiangsu) Nutraceutical
- Amyris Brasil Pesquisa e Desenvolvimento
- Biocare Copenhagen A/S
- Fortitech
- Kensey Nash Corporation
- Martek Biosciences
- Ocean Nutrition
- SRF Limited
- Tortuga Companhia Zootécnica Agrária
- Twilmij
- Unitech Industries Ltd
- Valley Research Group
- Amerifit Brands Inc L2
- Cytori Therapeutics L2
- IntraLuminal Therapeutics L2
- Azaya Therapeutics, Inc L3
Recent trials (50)
- NCT07093463Lead sponsorN/AJul 18, 2025
- NCT06578455Lead sponsorPhase 1Aug 30, 2024
- NCT06058403CollaboratorN/AOct 3, 2023
- NCT05803811Lead sponsorN/ADec 12, 2022
- NCT05574530CollaboratorN/AOct 12, 2022
- NCT05488106CollaboratorN/ASep 1, 2022
- NCT05598619Lead sponsorN/AJul 1, 2022
- NCT05277376Lead sponsorPhase 3Mar 15, 2022
- NCT05254912Study directorPhase 2Mar 7, 2022
- NCT05254912Lead sponsorPhase 2Mar 7, 2022
- NCT05254925Lead sponsorPhase 2Feb 28, 2022
- NCT05254925Study directorPhase 2Feb 28, 2022
- NCT05260359Lead sponsorPhase 2Feb 23, 2022
- NCT05205785Lead sponsorN/AJan 1, 2022
- NCT05205785Study directorN/AJan 1, 2022
Details
- Founded
- Limburg, NL Jun 1, 1902
- Last known activity
- Jul 18, 2025